tiprankstipranks
Advertisement
Advertisement

QURE Stock Latest News

Acting FDA head vows to block political interference, Endpoint News says
The FlyActing FDA head vows to block political interference, Endpoint News says
7d ago
AZN
BMY
FDA issues draft guidance to help accelerated cell, gene therapies for patients
PremiumThe Fly
FDA issues draft guidance to help accelerated cell, gene therapies for patients
9d ago
AZN
BMY
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
PremiumThe Fly
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
1M ago
AZN
BMY
Trump Trade: U.S. plans AI security order without required model tests
PremiumThe Fly
Trump Trade: U.S. plans AI security order without required model tests
1M ago
DYN
RNA
Trump approves plan to fire FDA head Marty Makary, CBS reports
PremiumThe Fly
Trump approves plan to fire FDA head Marty Makary, CBS reports
1M ago
DYN
RNA
uniQure price target lowered to $50 from $70 at H.C. Wainwright
PremiumThe FlyuniQure price target lowered to $50 from $70 at H.C. Wainwright
1M ago
QURE
uniQure price target raised to $28 from $14 at Stifel
Premium
The Fly
uniQure price target raised to $28 from $14 at Stifel
1M ago
QURE
uniQure reports Q1 EPS (85c), consensus (75c)
Premium
The Fly
uniQure reports Q1 EPS (85c), consensus (75c)
1M ago
QURE
uniQure price target raised to $37 from $31 at Chardan
PremiumThe Fly
uniQure price target raised to $37 from $31 at Chardan
1M ago
QURE
uniQure advances AMT-130 toward UK marketing approval
PremiumCompany Announcements
uniQure advances AMT-130 toward UK marketing approval
1M ago
8K
QURE
Which 3 Stocks Have the Most Upside in U.S. Chess Champion Hikaru’s Portfolio?
PremiumMarket News
Which 3 Stocks Have the Most Upside in U.S. Chess Champion Hikaru’s Portfolio?
2M ago
APP
ABVX
uniQure price target raised to $10 from $9 at Goldman Sachs
PremiumThe Fly
uniQure price target raised to $10 from $9 at Goldman Sachs
2M ago
QURE
uniQure call volume above normal and directionally bullish
PremiumThe FlyuniQure call volume above normal and directionally bullish
2M ago
QURE
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
Premium
The Fly
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
2M ago
DYN
RNA
uniQure put volume heavy and directionally bearish
Premium
The Fly
uniQure put volume heavy and directionally bearish
2M ago
QURE
uniQure put volume heavy and directionally bearish
PremiumThe Fly
uniQure put volume heavy and directionally bearish
2M ago
QURE
Passage Bio initiated with an Outperform at Oppenheimer
PremiumThe Fly
Passage Bio initiated with an Outperform at Oppenheimer
2M ago
PASG
QURE
U.S. Chess Champion Dips Below the S&P as Tech Stock Picks Falter
PremiumMarket News
U.S. Chess Champion Dips Below the S&P as Tech Stock Picks Falter
2M ago
HOOD
QURE
uniQure Investors Sue Company Over Huntington’s Disease Drug Study Claims
PremiumMarket News
uniQure Investors Sue Company Over Huntington’s Disease Drug Study Claims
3M ago
QURE
uniQure price target lowered to $25 from $31 at Barclays
PremiumThe FlyuniQure price target lowered to $25 from $31 at Barclays
3M ago
QURE
uniQure upgraded to Outperform from Neutral at Mizuho
Premium
The Fly
uniQure upgraded to Outperform from Neutral at Mizuho
3M ago
QURE
uniQure upgraded at Mizuho on potential improvement in regulatory outlook
Premium
The Fly
uniQure upgraded at Mizuho on potential improvement in regulatory outlook
3M ago
QURE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >